Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Reni Benjamin is an analyst at JMP Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/22/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 06/26/2024 | HOWL | Buy Now | Werewolf Therapeutics | $2.72 | 341.18% | $12 → $12 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 06/20/2024 | IOVA | Buy Now | Iovance Biotherapeutics | $7.95 | 189.31% | $25 → $23 | Maintains | Market Outperform | Get Alert |
| 06/18/2024 | KURA | Buy Now | Kura Oncology | $20.95 | 52.74% | $32 → $32 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 06/07/2024 | BPMC | Buy Now | Blueprint Medicines | $114.97 | 8.72% | $125 → $125 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 06/04/2024 | HOWL | Buy Now | Werewolf Therapeutics | $2.72 | 341.18% | $12 → $12 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/23/2024 | BCAB | Buy Now | BioAtla | $1.65 | 202.26% | $12 → $5 | Maintains | Market Outperform | Get Alert |
| 05/16/2024 | KURA | Buy Now | Kura Oncology | $20.95 | 52.74% | → $32 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/06/2024 | KURA | Buy Now | Kura Oncology | $20.95 | 52.74% | → $32 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/06/2024 | HOWL | Buy Now | Werewolf Therapeutics | $2.72 | 341.18% | → $12 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/03/2024 | BPMC | Buy Now | Blueprint Medicines | $114.97 | 8.72% | $114 → $125 | Maintains | Market Outperform | Get Alert |
| 04/30/2024 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | — | Downgrade | Market Outperform → Market Perform | Get Alert |
| 04/10/2024 | BPMC | Buy Now | Blueprint Medicines | $114.97 | -0.84% | → $114 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 04/03/2024 | STRO | Buy Now | Sutro Biopharma | $3.77 | 351.53% | → $17 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 04/03/2024 | HOWL | Buy Now | Werewolf Therapeutics | $2.72 | 341.18% | → $12 | Initiates | → Market Outperform | Get Alert |
| 03/28/2024 | BCAB | Buy Now | BioAtla | $1.65 | 625.43% | → $12 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/26/2024 | STRO | Buy Now | Sutro Biopharma | $3.77 | 351.53% | — | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/13/2024 | PRLD | Buy Now | Prelude Therapeutics | $5.26 | 33.08% | → $7 | Initiates | → Market Outperform | Get Alert |
| 03/01/2024 | SANA | Buy Now | Sana Biotechnology | $5.80 | 158.62% | $8 → $15 | Maintains | Market Outperform | Get Alert |
| 02/20/2024 | IOVA | Buy Now | Iovance Biotherapeutics | $7.95 | 214.47% | $18 → $25 | Maintains | Market Outperform | Get Alert |
| 02/16/2024 | BPMC | Buy Now | Blueprint Medicines | $114.97 | -0.84% | → $114 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 02/14/2024 | INCY | Buy Now | Incyte | $65.87 | — | — | Downgrade | Market Outperform → Market Perform | Get Alert |
| 01/31/2024 | KURA | Buy Now | Kura Oncology | $20.95 | 52.74% | $22 → $32 | Maintains | Market Outperform | Get Alert |
| 01/23/2024 | INBX | Buy Now | Inhibrx | $12.88 | — | — | Downgrade | Market Outperform → Market Perform | Get Alert |
| 01/16/2024 | BPMC | Buy Now | Blueprint Medicines | $114.97 | -0.84% | → $114 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 01/10/2024 | AMAM | Buy Now | Ambrx Biopharma | — | — | — | Downgrade | Market Outperform → Market Perform | Get Alert |
| 01/05/2024 | ALLO | Buy Now | Allogene Therapeutics | $2.85 | — | — | Downgrade | Market Outperform → Market Perform | Get Alert |
| 12/20/2023 | BCYC | Buy Now | Bicycle Therapeutics | $22.33 | 43.3% | $44 → $32 | Maintains | Market Outperform | Get Alert |
| 12/13/2023 | INCY | Buy Now | Incyte | $65.87 | 41.19% | → $93 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 12/05/2023 | BCAB | Buy Now | BioAtla | $1.65 | 625.43% | → $12 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 11/29/2023 | AMAM | Buy Now | Ambrx Biopharma | — | — | → $15 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 11/20/2023 | INBX | Buy Now | Inhibrx | $12.88 | 109.63% | → $27 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 11/20/2023 | AMAM | Buy Now | Ambrx Biopharma | — | — | → $15 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 10/12/2023 | SANA | Buy Now | Sana Biotechnology | $5.80 | 37.93% | $9 → $8 | Maintains | Market Outperform | Get Alert |
| 09/25/2023 | SANA | Buy Now | Sana Biotechnology | $5.80 | 55.17% | → $9 | Initiates | → Market Outperform | Get Alert |
| 09/25/2023 | AMAM | Buy Now | Ambrx Biopharma | — | — | → $15 | Initiates | → Market Outperform | Get Alert |
| 09/15/2023 | IOVA | Buy Now | Iovance Biotherapeutics | $7.95 | 126.42% | → $18 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 09/12/2023 | BCYC | Buy Now | Bicycle Therapeutics | $22.33 | 97.04% | → $44 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 08/23/2023 | LVTX | Buy Now | LAVA Therapeutics | $2.08 | 188.7% | → $6 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 08/23/2023 | INBX | Buy Now | Inhibrx | $12.88 | 109.63% | $35 → $27 | Maintains | Outperform | Get Alert |
| 08/17/2023 | IOVA | Buy Now | Iovance Biotherapeutics | $7.95 | 126.42% | → $18 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 08/14/2023 | STRO | Buy Now | Sutro Biopharma | $3.77 | 351.53% | → $17 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 08/07/2023 | BPMC | Buy Now | Blueprint Medicines | $114.97 | -0.84% | → $114 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 08/04/2023 | BCYC | Buy Now | Bicycle Therapeutics | $22.33 | 97.04% | $46 → $44 | Maintains | Outperform | Get Alert |
| 08/02/2023 | INCY | Buy Now | Incyte | $65.87 | 41.19% | → $93 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 08/02/2023 | BCAB | Buy Now | BioAtla | $1.65 | 625.43% | → $12 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 07/25/2023 | INCY | Buy Now | Incyte | $65.87 | 41.19% | → $93 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 06/27/2023 | STRO | Buy Now | Sutro Biopharma | $3.77 | 351.53% | → $17 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 06/27/2023 | ACET | Buy Now | Adicet Bio | $1.20 | — | — | Downgrade | Market Outperform → Market Perform | Get Alert |
| 06/15/2023 | LVTX | Buy Now | LAVA Therapeutics | $2.08 | 188.7% | → $6 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 06/13/2023 | KURA | Buy Now | Kura Oncology | $20.95 | 5.01% | → $22 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 06/12/2023 | STRO | Buy Now | Sutro Biopharma | $3.77 | 351.53% | → $17 | Reiterates | → Market Outperform | Get Alert |
| 06/09/2023 | LVTX | Buy Now | LAVA Therapeutics | $2.08 | 188.7% | → $6 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 06/05/2023 | IOVA | Buy Now | Iovance Biotherapeutics | $7.95 | 126.42% | → $18 | Reiterates | → Market Outperform | Get Alert |
| 06/05/2023 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | → $23 | Reiterates | → Market Outperform | Get Alert |
| 06/05/2023 | ALLO | Buy Now | Allogene Therapeutics | $2.85 | 426.32% | → $15 | Reiterates | → Market Outperform | Get Alert |
| 05/30/2023 | IOVA | Buy Now | Iovance Biotherapeutics | $7.95 | 126.42% | → $18 | Reinstates | Market Outperform → Market Perform | Get Alert |
| 05/24/2023 | CTIC | Buy Now | CTI BioPharma | — | — | — | Maintains | Market Perform | Get Alert |
| 05/23/2023 | BPMC | Buy Now | Blueprint Medicines | $114.97 | -0.84% | → $114 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/17/2023 | STRO | Buy Now | Sutro Biopharma | $3.77 | 351.53% | → $17 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/15/2023 | CUE | Buy Now | Cue Biopharma | $0.83 | 1711.59% | → $15 | Reiterates | Outperform → Outperform | Get Alert |
| 05/15/2023 | BCAB | Buy Now | BioAtla | $1.65 | 625.43% | $12 → $12 | Reiterates | Outperform → Outperform | Get Alert |
| 05/15/2023 | ACET | Buy Now | Adicet Bio | $1.20 | 1482.01% | → $19 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/11/2023 | BCYC | Buy Now | Bicycle Therapeutics | $22.33 | 106% | $46 → $46 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/11/2023 | CTIC | Buy Now | CTI BioPharma | — | — | — | Downgrade | Market Outperform → Market Perform | Get Alert |
| 05/05/2023 | BPMC | Buy Now | Blueprint Medicines | $114.97 | -0.84% | — | Reiterates | → Market Outperform | Get Alert |
| 05/05/2023 | BCYC | Buy Now | Bicycle Therapeutics | $22.33 | 106% | → $46 | Reiterates | → Market Outperform | Get Alert |
| 05/05/2023 | ALLO | Buy Now | Allogene Therapeutics | $2.85 | 426.32% | $19 → $15 | Maintains | Outperform | Get Alert |
| 05/04/2023 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | → $23 | Reiterates | → Market Outperform | Get Alert |
| 05/04/2023 | INCY | Buy Now | Incyte | $65.87 | 41.19% | $113 → $93 | Maintains | Outperform | Get Alert |
| 04/26/2023 | SPPI | Buy Now | Spectrum Pharma | — | — | — | Downgrade | Market Outperform → Market Perform | Get Alert |
| 04/19/2023 | INCY | Buy Now | Incyte | $65.87 | 71.55% | → $113 | Reiterates | → Market Outperform | Get Alert |
| 04/18/2023 | BCYC | Buy Now | Bicycle Therapeutics | $22.33 | 106% | → $46 | Reiterates | → Market Outperform | Get Alert |
| 04/18/2023 | ALLO | Buy Now | Allogene Therapeutics | $2.85 | 566.67% | → $19 | Reiterates | → Market Outperform | Get Alert |
| 04/17/2023 | KURA | Buy Now | Kura Oncology | $20.95 | 5.01% | → $22 | Reiterates | → Market Outperform | Get Alert |
| 04/03/2023 | STRO | Buy Now | Sutro Biopharma | $3.77 | 351.53% | $20 → $17 | Maintains | Outperform | Get Alert |
| 03/30/2023 | BPMC | Buy Now | Blueprint Medicines | $114.97 | -0.84% | → $114 | Reiterates | → Market Outperform | Get Alert |
| 03/28/2023 | INCY | Buy Now | Incyte | $65.87 | 71.55% | → $113 | Reiterates | → Market Outperform | Get Alert |
| 03/27/2023 | BCAB | Buy Now | BioAtla | $1.65 | 625.43% | $17 → $12 | Maintains | Outperform | Get Alert |
| 03/15/2023 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | → $23 | Reiterates | → Market Outperform | Get Alert |
| 03/14/2023 | SGEN | Buy Now | Seagen | — | — | — | Downgrade | Market Outperform → Market Perform | Get Alert |
| 03/07/2023 | INCY | Buy Now | Incyte | $65.87 | 71.55% | → $113 | Reiterates | → Market Outperform | Get Alert |
| 03/07/2023 | CTIC | Buy Now | CTI BioPharma | — | — | → $9 | Reiterates | → Market Outperform | Get Alert |
| 02/17/2023 | SGEN | Buy Now | Seagen | — | — | $142 → $168 | Maintains | Market Outperform | Get Alert |
| 02/13/2023 | INCY | Buy Now | Incyte | $65.87 | 71.55% | → $113 | Reiterates | → Market Outperform | Get Alert |
| 02/06/2023 | SPPI | Buy Now | Spectrum Pharma | — | — | → $4 | Reiterates | → Market Outperform | Get Alert |
| 02/06/2023 | SGEN | Buy Now | Seagen | — | — | → $142 | Reiterates | → Market Outperform | Get Alert |
| 02/06/2023 | INCY | Buy Now | Incyte | $65.87 | 71.55% | → $113 | Reiterates | → Market Outperform | Get Alert |
| 02/06/2023 | CTIC | Buy Now | CTI BioPharma | — | — | → $9 | Reiterates | → Market Outperform | Get Alert |
| 02/06/2023 | BPMC | Buy Now | Blueprint Medicines | $114.97 | -0.84% | → $114 | Reiterates | → Market Outperform | Get Alert |
| 02/01/2023 | SPPI | Buy Now | Spectrum Pharma | — | — | → $4 | Reiterates | → Market Outperform | Get Alert |
| 01/09/2023 | EFTR | Buy Now | eFFECTOR Therapeutics | $0.06 | 1718.18% | $50 → $25 | Maintains | Market Outperform | Get Alert |
| 11/21/2022 | IOVA | Buy Now | Iovance Biotherapeutics | $7.95 | 164.15% | $25 → $21 | Maintains | Market Outperform | Get Alert |
| 11/17/2022 | EFTR | Buy Now | eFFECTOR Therapeutics | $0.06 | 3536.36% | $125 → $50 | Maintains | Market Outperform | Get Alert |
| 11/09/2022 | BCYC | Buy Now | Bicycle Therapeutics | $22.33 | 106% | $70 → $46 | Maintains | Market Outperform | Get Alert |
| 11/04/2022 | BPMC | Buy Now | Blueprint Medicines | $114.97 | -0.84% | $152 → $114 | Maintains | Market Outperform | Get Alert |
| 11/02/2022 | SGEN | Buy Now | Seagen | — | — | $196 → $142 | Maintains | Market Outperform | Get Alert |
| 09/15/2022 | LVTX | Buy Now | LAVA Therapeutics | $2.08 | 188.7% | → $6 | Initiates | → Market Outperform | Get Alert |
| 09/15/2022 | BCAB | Buy Now | BioAtla | $1.65 | 927.69% | → $17 | Initiates | → Market Outperform | Get Alert |
| 08/11/2022 | EFTR | Buy Now | eFFECTOR Therapeutics | $0.06 | 8990.91% | $200 → $125 | Maintains | Market Outperform | Get Alert |
| 08/09/2022 | CTIC | Buy Now | CTI BioPharma | — | — | $6 → $9 | Maintains | Market Outperform | Get Alert |
| 08/08/2022 | CGEN | Buy Now | Compugen | $1.87 | 113.9% | $8 → $4 | Maintains | Market Outperform | Get Alert |
| 08/05/2022 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | → $23 | Upgrade | Market Perform → Market Outperform | Get Alert |
| 07/08/2022 | SGEN | Buy Now | Seagen | — | — | $157 → $196 | Maintains | Market Outperform | Get Alert |
| 03/17/2022 | ACET | Buy Now | Adicet Bio | $1.20 | 1648.54% | $30 → $21 | Maintains | Market Outperform | Get Alert |
| 03/03/2022 | BCYC | Buy Now | Bicycle Therapeutics | $22.33 | 213.48% | $85 → $70 | Maintains | Market Outperform | Get Alert |
| 03/02/2022 | INBX | Buy Now | Inhibrx | $12.88 | 210.56% | $53 → $40 | Maintains | Market Outperform | Get Alert |
| 03/02/2022 | CTIC | Buy Now | CTI BioPharma | — | — | $4 → $5 | Maintains | Market Outperform | Get Alert |
| 02/16/2022 | SGEN | Buy Now | Seagen | — | — | $201 → $142 | Maintains | Market Outperform | Get Alert |
| 01/25/2022 | EFTR | Buy Now | eFFECTOR Therapeutics | $0.06 | 14445.45% | $825 → $200 | Maintains | Market Outperform | Get Alert |
| 09/21/2021 | EFTR | Buy Now | eFFECTOR Therapeutics | $0.06 | 59900% | → $825 | Initiates | → Market Outperform | Get Alert |
| 10/12/2017 | ADVM | Buy Now | Adverum Biotechnologies | $8.00 | -25% | → $60 | Initiates | → Outperform | Get Alert |
